Strategic Communication and Public Relations

Making efficient use of Big Data in medicine

The DKFZ participates in a project by the Helmholtz Association on research data management

No. 42c | 14/10/2016 | by Sel

Large experiments and simulations in science today generate ever increasing amounts of data. In order to turn this data and information into insights and knowledge however, scientists also need storage capacities and analytical potential of a new quality. The Helmholtz Association is now leading the way in storing data permanently, securely and re-usably. In order to manage Big Data in science, the association has founded the Helmholtz Data Federation (HDF). Around 49.5 million Euros will be invested over the next 5 years in multi-thematic data centers and in modern data management. In the context of the HDF initiative coordinated by KIT in Karlsruhe, the DKFZ is responsible for the data accruing in healthcare.

© dkfz.de

"Biomedical research generates ever larger quantities of data that need to be analyzed. In cancer research for example, this happens as a result of the sequencing of the entire genetic material of cancer cells, or on account of new imaging procedures", explains Michael Boutros, Scientific Director at DKFZ.

The DKFZ cooperates with other Helmholtz Research centers to develop new methods to utilize this enormous wealth of data in the best possible way. This includes pooling scientific data, sharing data whilst maintaining data ownership, using data across disciplinary boundaries, and providing reliable data archiving capabilities. "Everybody is now talking about Big Data. In medical research, a vast amount of data is generated, which needs to be pooled, so that it can be used in a meaningful way. The integration of data harbors great potential to discover new medically relevant correlations. The combined results of genome analysis and images from radiology can provide valuable clues about effective treatment for cancer patients. This however demands specialized technologies and methods, which we intend to develop further within the framework of the HDF" explains Roland Eils, who coordinates the contribution of medical research in the HDF together with the head of IT at DKFZ, Holger Haas.

Further information:

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. More than 1,300 scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They are developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to all questions on cancer.

Jointly with partners from the university hospitals, the DKFZ operates the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden, and the Hopp Children's Tumour Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of the six German Centers for Health Research, the DKFZ maintains translational centers at seven university partner locations. NCT and DKTK sites combine excellent university medicine with the high-profile research of the DKFZ. They contribute to the endeavor of transferring promising approaches from cancer research to the clinic and thus improving the chances of cancer patients.

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS